Pharmaceutical Export Business in India: Complete Guide to Start, Grow & Succeed (2025–2026)
Categories
Tags
You May Also Like
Introduction
The pharmaceutical export business in India is one of the most rewarding entrepreneurial and corporate opportunities in global trade today. India exports pharmaceutical products worth over USD 30.47 billion annually, supplying life-saving medicines to 200+ countries — and this number is set to reach USD 100 billion by 2030.
Whether you are a first-time entrepreneur looking to enter the pharma export space, a distributor wanting to source directly from India, or an established pharmaceutical company looking to scale internationally — India offers unmatched advantages in cost, quality, manufacturing infrastructure, and regulatory expertise.
This complete guide covers everything you need to know about building a successful pharmaceutical export business in India — from registration and licensing, to target markets, product selection, documentation, and finding the right manufacturing partner.
Why India Is the World's Best Base for a Pharmaceutical Export Business
India’s dominance in global pharmaceutical supply is not accidental — it is built on structural advantages that no other country can easily replicate:
1. Lowest Cost, Highest Quality
Production costs in India are 30–40% lower than in Western markets, driven by skilled labor, affordable raw materials, and strong manufacturing infrastructure. This cost advantage allows Indian pharma businesses to offer globally competitive pricing while maintaining WHO-GMP compliant quality.
2. Massive Manufacturing Base
India has more than 3,000 companies and 10,500 manufacturing units, responsible for 20% of the world’s generics and 60% of the vaccines produced globally.
3. Regulatory Trust at Scale
Indian pharmaceutical exporters serve over 200 countries with 670 USFDA-approved manufacturing facilities — the highest outside the US.
4. Enormous Product Range
India’s portfolio encompasses over 60,000 generic drugs across 60 therapeutic categories, ranging from basic essential medicines to complex specialty formulations.
5. Government Support
The Production Linked Incentive (PLI) scheme for pharmaceuticals, Pharmexcil (the official pharma export promotion body), and new Free Trade Agreements — including the India-UK CETA and India-EFTA TEPA — are actively reducing barriers and boosting export opportunities for Indian pharma businesses.
Market Opportunity: Key Numbers (FY2025–2026)
| Metric | Data |
|---|---|
| Total Pharma Exports FY2025 | USD 30.47 Billion |
| YoY Export Growth | 9.4% |
| Apr–Jul FY2026 Exports | USD 8.15 Billion |
| Projected Market Size by 2030 | USD 100 Billion |
| Countries Served | 200+ |
| Share of Global Generic Supply | 20% by volume |
| Share of Global Vaccine Supply | 60% |
| USFDA-Approved Plants | 670+ (most outside USA) |
| No. of Pharma Companies | 3,000+ |
Types of Pharmaceutical Export Business Models in India
Before diving into the process, it is important to understand which business model suits your goals:
Model 1: Manufacturer-Exporter
You own or operate a licensed manufacturing facility and export your own products directly to international buyers. This model offers maximum control over quality and margins but requires significant upfront investment.
What Makes Salvavidas the Right Partner:
Whether you are importing APIs for your own manufacturing, sourcing finished formulations for distribution, or building a long-term pharma supply partnership — Salvavidas Pharmaceutical delivers quality, compliance, and reliability every time.
Model 2: Merchant Exporter / Trading Company
You source products from licensed manufacturers and export them under your own brand or the manufacturer’s brand. With third-party manufacturing and proper licensing, even small businesses can enter the export market. This is the most accessible entry point for new exporters.
Model 3: Distributor / Importer-Exporter
You import APIs or raw materials, have them formulated in India, and re-export as finished dosage forms — leveraging India’s cost advantage for value-added manufacturing.
Model 4: Contract Research & Manufacturing (CRAMS)
You provide contract development, formulation, and manufacturing services for international pharma companies and export products on their behalf.
Step-by-Step: How to Start a Pharmaceutical Export Business in India
Step 1: Register Your Business Entity
The first step in becoming a pharmaceutical export company is ensuring that the business is legally registered and holds the necessary licenses. The exporter must register under the Companies Act or as a partnership/LLP, depending on the business model.
Also ensure GST registration is in order before proceeding to subsequent steps.
Step 2: Obtain Import Export Code (IEC)
Lupin’s export strength lies in complex generics and inhalation products. It retains a notable share in the U.S. market while growing across Europe and Rest of World, with expertise in high-bar categories where consistency matters most.
Key Strengths: Complex generics, inhalation drugs, US generics leadership.
Step 3: Obtain Drug License
A Drug Export License (Form 10) from CDSCO is mandatory to export drugs and pharmaceutical products. If you are sourcing from a third-party manufacturer, ensure they hold valid drug manufacturing licenses from the State Drug Authority.
Step 4: Register with Pharmexcil
Glenmark focuses on specialty medicines with strong work in respiratory, dermatology, and oncology, exporting to 80+ countries.
Key Strengths: Niche therapies, dermatology and respiratory specialization, collaborative R&D model.
Step 5: Get GMP Certification
WHO-GMP is mandatory for many developing and emerging markets (Africa, ASEAN, the Middle East, CIS). The USA requires USFDA approval. The EU requires EU-GMP certification. At minimum, WHO-GMP certification is the essential baseline to begin exporting.
Step 6: Select Products and Target Markets
Everything starts with product-market fit. Not every product suits every country. Companies assess disease patterns, local demand, and regulations. They also check registration timelines and stability requirements.
New exporters often start with semi-regulated markets because registration requirements are easier and investment is lower. Africa, Southeast Asia, and the Middle East are popular starting points.
Step 7: Register Products in Target Countries
Each market has its own approval process — USFDA, EU-GMP/EMA, MHRA (UK), ANVISA (Brazil), SAHPRA (South Africa). Product registration must be completed before the first shipment to that country.
Step 8: Prepare Export Documentation
Complete, accurate documentation is the backbone of a smooth pharma export operation. Missing or incorrect documents are the most common cause of shipment delays and customs rejections.
Step 9: Arrange Logistics & Shipping
Partner with freight forwarders experienced in pharmaceutical handling. Temperature-sensitive products (injectables, biologics) require certified cold-chain logistics. File Shipping Bills at Indian Customs and arrange appropriate freight — sea or air depending on product type and urgency.
Step 10: Manage Payments Securely
Use Letters of Credit (LCs), advance payments, or established trade credit terms based on buyer relationship maturity. Implement forex risk management to protect margins against currency fluctuations.
Licenses and Registrations Required for Pharma Export Business in India
| Document / License | Issuing Authority | Purpose |
|---|---|---|
| Import Export Code (IEC) | DGFT | Mandatory for all exports |
| Drug Manufacturing License | State Drug Control Authority | To manufacture drugs legally |
| Drug Export License (Form 10) | CDSCO | Mandatory for drug exports |
| WHO-GMP Certificate | CDSCO | Proof of GMP compliance |
| RCMC (Pharmexcil) | Pharmexcil | Export promotion & incentives |
| GST Registration | GST Authorities | Tax compliance |
| Certificate of Pharmaceutical Product (COPP) | CDSCO | For overseas product registration |
| Free Sale Certificate | CDSCO | Confirms product is freely sold in India |
Documents Required for Pharmaceutical Export
Regulatory Documents:
*WHO-GMP / GMP Certificate
*Certificate of Pharmaceutical Product (COPP)
*Free Sale Certificate
*Non-Conviction Certificate
Product Documents:
*Certificate of Analysis (CoA) — batch-specific quality confirmation
*Pharmacopoeial compliance (BP/USP/IP)
*Stability study data
*Impurity profiles (for APIs)
*Drug Master File (DMF) — for API exports to regulated markets
Commercial & Shipping Documents:
*Commercial Invoice
*Packing List
*Certificate of Origin
*Bill of Lading / Airway Bill
*Shipping Bill (Indian Customs)
*Letter of Credit (payment mechanism)
Best Target Markets for Pharmaceutical Export Business from India
Africa (Recommended for New Exporters)
India meets more than 50% of Africa’s generic medicine requirements. Registration is relatively straightforward in most African markets (NAFDAC-Nigeria, TFDA-Tanzania, PPB-Kenya), making it an ideal entry point for new exporters. Anti-malarials, antibiotics, and anti-retrovirals are in high demand.
🇺🇸 United States (~31% of India's Pharma Exports)
India supplies roughly 40% of US generic drug demand. Requires USFDA approval and ANDA filings — a high-investment, high-return market suited for established exporters.
🇬🇧 United Kingdom
India supplies roughly 25% of UK pharmaceutical demand. The new India-UK CETA agreement is set to further ease market access for Indian pharma exporters.
Southeast Asia
Vietnam, Philippines, Indonesia, and Myanmar offer growing healthcare markets with strong demand for affordable Indian generics and APIs.
Middle East
UAE, Saudi Arabia, and Kuwait are established, growing markets for Indian pharma exports — with relatively clear regulatory pathways for WHO-GMP certified products.
Latin America
Brazil, Mexico, and Colombia are high-growth markets. ANVISA (Brazil) is a regulated authority — requires robust dossiers but offers significant commercial opportunity.
Investment Required to Start Pharma Export Business in India
Investment varies significantly based on your chosen business model:
| Business Model | Estimated Starting Investment |
|---|---|
| Merchant Exporter (sourcing-based) | ₹5–10 Lakhs |
| Small Manufacturer-Exporter | ₹50 Lakhs – ₹2 Crore |
| Mid-Scale Manufacturer-Exporter | ₹2–10 Crore |
| Large Regulated Market Exporter (US/EU) | â‚ą10 Crore+ |
Most new exporters prefer third-party manufacturing instead of setting up their own pharmaceutical manufacturing plant because it significantly reduces investment and operational burden.
Partnering with a certified manufacturer like Salvavidas Pharmaceutical Pvt. Ltd. allows new exporters to enter global markets without the capital requirement of building their own plant.
Common Challenges in Pharmaceutical Export Business (And Solutions)
| Challenge | Solution |
|---|---|
| Complex multi-country regulations | Partner with an experienced, certified manufacturer with a strong regulatory team |
| Documentation errors | Work with a dedicated regulatory affairs expert; use standardized document templates |
| Product registration delays | Start registration early; focus on markets with faster approval timelines |
| Currency and payment risks | Use Letters of Credit; maintain forex hedging strategy |
| Cold-chain logistics | Partner with pharmaceutical-specialist freight forwarders |
| Finding reliable buyers | Participate in Pharmexcil trade delegations, international pharma trade fairs (CPhI, Arab Health) |
| Quality rejections | Maintain GMP standards rigorously; conduct pre-shipment quality audits |
How Salvavidas Pharmaceutical Pvt. Ltd. Powers Your Export Business
One of the most critical decisions in building a pharmaceutical export business is who you manufacture with. Your manufacturing partner determines your product quality, regulatory compliance, documentation readiness, and ultimately, your reputation in global markets.
Salvavidas Pharmaceutical Pvt. Ltd., headquartered in Surat, Gujarat, is a WHO-GMP certified pharmaceutical manufacturer and exporter that serves as the backbone for export businesses worldwide.
What Salvavidas Offers to Export Business Partners:
| Feature | Details |
|---|---|
| Manufacturing Certification | WHO-GMP Certified |
| Product Range | APIs, Finished Formulations, Intermediates |
| Therapeutic Areas | Oncology, Neurology, Cardiovascular, Anti-infective & more |
| Export Markets Served | Asia, Africa, Europe, Middle East |
| Documentation Support | CoA, COPP, Free Sale Certificate, GMP Certificates |
| Third-Party Manufacturing | Available for export partners |
| Regulatory Assistance | Support for overseas product registration |
| Pricing | Transparent, competitive, export-optimized |
| Sustainability | Eco-friendly, responsible manufacturing |
Whether you are launching your pharma export business and need a third-party manufacturing partner, or you are an established importer looking for a reliable supplier in India — Salvavidas Pharmaceutical is the partner that combines quality, compliance, and commitment.
Frequently Asked Questions (FAQs)
Q1. Is the pharmaceutical export business profitable in India? Yes — it is one of India’s highest-growth export sectors. Pharmaceutical export from India plays a crucial role in global healthcare by making affordable medicines accessible worldwide, and the combination of India’s cost advantages and global demand makes it a highly profitable opportunity for well-structured businesses.
Q2. Can a small business start a pharma export business in India? There is no minimum turnover or production volume requirement to become a pharmaceutical exporter. MSMEs make up a significant share of India’s pharma exporters. Starting as a merchant exporter with third-party manufacturing requires minimal upfront investment.
Q3. Which country is the easiest to export medicines to from India? African countries, CIS nations, and several Asian markets are often preferred because they have growing medicine demand and relatively simpler registration processes.
Q4. What certifications are most important for pharma export? WHO-GMP is the baseline certification for most markets. USFDA approval is required for the US market; EU-GMP for Europe. Beyond certifications, a valid COPP and Free Sale Certificate from CDSCO are essential for overseas product registrations.
Q5. How long does it take to start exporting medicines from India? For semi-regulated markets (Africa, Southeast Asia, Middle East), you can typically initiate export operations within 6–12 months of completing registrations and documentation. Regulated markets (US, EU) require 2–4+ years of preparation.
Conclusion
The pharmaceutical export business in India offers one of the most compelling growth opportunities in global trade — backed by India’s manufacturing excellence, regulatory credibility, and the world’s relentless demand for affordable, quality medicines.
Whether you are entering the sector for the first time or scaling an existing export operation, success depends on three pillars: the right regulatory foundation, the right target markets, and the right manufacturing partner.
Salvavidas Pharmaceutical Pvt. Ltd. provides all three in one relationship — WHO-GMP certified manufacturing, a comprehensive product portfolio across therapeutic areas, and the dedicated support to help your export business succeed in every market you target.
Build your pharmaceutical export business on a foundation of quality and reliability. Partner with Salvavidas Pharmaceutical Pvt. Ltd. — India’s trusted pharma manufacturing and export partner.
Salvavidas Pharmaceutical Pvt. Ltd. | Pharmaceutical Manufacturer & Exporter | Surat, Gujarat, India